Outcome of NSCLC (non-small cell lung cancer) patients treated with second line pembrolizumab: experience from the Portsmouth Oncology Centre
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI